1. Home
  2. NEPH vs NXN Comparison

NEPH vs NXN Comparison

Compare NEPH & NXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • NXN
  • Stock Information
  • Founded
  • NEPH 1997
  • NXN 1992
  • Country
  • NEPH United States
  • NXN United States
  • Employees
  • NEPH N/A
  • NXN N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • NXN Trusts Except Educational Religious and Charitable
  • Sector
  • NEPH Health Care
  • NXN Finance
  • Exchange
  • NEPH Nasdaq
  • NXN Nasdaq
  • Market Cap
  • NEPH 42.6M
  • NXN 45.4M
  • IPO Year
  • NEPH 2004
  • NXN N/A
  • Fundamental
  • Price
  • NEPH $3.93
  • NXN $11.94
  • Analyst Decision
  • NEPH Strong Buy
  • NXN
  • Analyst Count
  • NEPH 2
  • NXN 0
  • Target Price
  • NEPH $5.50
  • NXN N/A
  • AVG Volume (30 Days)
  • NEPH 50.3K
  • NXN 9.7K
  • Earning Date
  • NEPH 11-06-2025
  • NXN 01-01-0001
  • Dividend Yield
  • NEPH N/A
  • NXN 4.23%
  • EPS Growth
  • NEPH N/A
  • NXN N/A
  • EPS
  • NEPH 0.12
  • NXN 0.24
  • Revenue
  • NEPH $16,684,000.00
  • NXN N/A
  • Revenue This Year
  • NEPH $24.38
  • NXN N/A
  • Revenue Next Year
  • NEPH $5.60
  • NXN N/A
  • P/E Ratio
  • NEPH $32.97
  • NXN $48.42
  • Revenue Growth
  • NEPH 21.16
  • NXN N/A
  • 52 Week Low
  • NEPH $1.36
  • NXN $10.64
  • 52 Week High
  • NEPH $5.00
  • NXN $12.45
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 50.10
  • NXN 71.02
  • Support Level
  • NEPH $3.62
  • NXN $11.71
  • Resistance Level
  • NEPH $4.55
  • NXN $11.95
  • Average True Range (ATR)
  • NEPH 0.35
  • NXN 0.09
  • MACD
  • NEPH -0.04
  • NXN 0.01
  • Stochastic Oscillator
  • NEPH 33.33
  • NXN 98.75

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About NXN Nuveen New York Select Tax-Free Income Portfolio

Nuveen NY Select Tax-Free Income Port is a diversified closed-end management investment company. Its investment objective are to provide current income exempt from regular federal and New Jersey income tax, and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

Share on Social Networks: